Cure My Disease

Don't miss your cure!

 Log in / Sign up

Scientists study blood and lung fluid to unlock secrets of ICU illnesses

NCT ID NCT05591924

Recruiting now Knowledge-focused Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is observing 1,000 critically ill ICU patients to learn how their bodies respond to life-threatening infections and injuries. Researchers will collect blood and lung fluid samples to identify biological factors that could lead to earlier diagnosis and new treatments for conditions like sepsis and ARDS. Participants must be adults admitted to the ICU within the last 48 hours.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this study could help doctors diagnose critical illnesses earlier and discover new treatments for conditions like sepsis and ARDS.

What could go wrong

This is an observational study, not a treatment trial. It collects data but does not test any therapy, so direct patient benefits are uncertain.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INFLAMMATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute respiratory distress syndrome Cognition Disorders cognitive disorder Critical Illness infectious disease with sepsis Inflammation inflammatory disease Pneumonia, Ventilator-Associated Sepsis toxic shock syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ARDS CRITICAL ILLNESS IMMUNE SUPPRESSION INFLAMMATION NEUROCOGNITIVE DYSFUNCTION SEPSIS SHOCK, SEPTIC SIRS VENTILATOR ASSOCIATED PNEUMONIA

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Aleks Leligdowicz

    RECRUITING

    London, Ontario, N6A 3K7, Canada

    Contact Phone: •••-•••-•••• Email: •••••@•••••